Image
Center for Translational Research (CTR) 2026 Workshop
Personalized, Predictive and Preventive Healthcare Innovations (P3HI)
HealthTech, Digital Health and AI Trends
Sponsored by
NSF ART (Accelerating Research Translation) Program at NJIT
National Academy of Inventors (NAI) – NJIT Chapter
Co-organizers and Co-Chairs
Atam P. Dhawan, Ph.D., Chief Strategic Innovation Officer, Senior Vice Provost
for Research, NJIT; Executive Director – Center for Translational Research
Arunan Skandarajah, Ph.D., Founder and Principal | Nalam Ventures, Former Small Business
Manager and Translational R&D and Commercialization Lead, Advanced
Research Projects Agency for Health (ARPA-H)
November 12, 2026 | 8.00 AM – 4.45 PM | Atrium, Campus Center
Register by November 2, 2026
The Center for Translational Research is committed to promoting excellence in collaborative research, innovation partnerships, entrepreneurial pathways, education, training, and infrastructure development to translate technology into applications with a high societal and economic impact. To execute on the CTR mission to enhance the research, innovation, and technology entrepreneurship ecosystem at NJIT, we have initiated a series of workshops on pathways to translational research and innovation partnerships, with panel discussions and breakout sessions giving faculty, postdocs, and students an opportunity to interact with experts on early and advanced translational research, tech transfer, licensing, and funding strategies for entrepreneurial activities. This CTR P3HI workshop focuses on translational research and innovative technology solutions to unmet needs in personalized, predictive, and preventive healthcare, improving global point-of-care healthcare, and driving future economic growth.
Why You Should Attend
Recent technological and pharmaceutical advances in healthcare have yielded tremendous improvements in the diagnosis and treatment of deadly maladies, from cardiac and brain disorders to cancers to infectious diseases. Yet a critical problem remains: the lack of “HealthTech” innovations available to all people for sustainable point-of-care, personalized monitoring towards preventive, predictive, and precision healthcare, understanding the onset and progression of pathological conditions, effective treatment and therapeutic intervention, and, more importantly, changing behavior to stay healthy in the long-term. Global healthcare, particularly in under-resourced communities in both impoverished and affluent nations, suffers from limited access to the life-changing remedies many of us take for granted. These disparities are unsustainable in a functioning global society.
What we need are affordable, simpler, and more effective healthcare technologies that can be easily administered across a wide range of settings. This is not merely a research and development challenge solved by ingenious inventors, but also one of market validation and translation. These devices must win the acceptance of users, clinicians, payors and regulatory agencies.
Partnerships among academic researchers, healthcare providers, regulators, and businesspeople that enable them to pool ideas, expertise, resources, and investments will accelerate the commercialization of new personalized, preventive, and precision healthcare applications. This workshop will take a step toward defining and building the necessary partnerships with the attendees at their core.
In addition, the CTR 2026 P3HI Workshop will feature a Translational Research and Innovation Showcase with the participation of HealthTech researchers and technology leaders from healthcare stakeholder sectors, including academia, medical and clinical centers, industry, federal agencies, foundations, and communities. Personalized medicine is here, and interacting with these innovators will put a fine point on the challenges and opportunities.
Who Should Attend
Individuals and organizations who hope to build a sustainable and impactful NJ regional ecosystem that delivers personalized, preventive, and precision healthcare domestically and abroad. Attendees will range from faculty, research staff, undergraduate and graduate students, postdocs and external partners, including major NJ universities, industry, medical centers, business accelerators, government, to community stakeholders. All who are pursuing or are interested in translational research, innovation, and technology development that builds to clinically meaningful use of these tools are encouraged to attend.
